From the Food and Drug Administration

JAMA. 2002 Jan 2;287(1):33.
No abstract available

MeSH terms

  • Adult
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Rheumatoid / drug therapy*
  • Breast Neoplasms / surgery*
  • Cryosurgery / instrumentation*
  • Fibroadenoma / surgery*
  • Humans
  • Interleukin 1 Receptor Antagonist Protein
  • Protein C / therapeutic use*
  • Receptors, Interleukin-1 / antagonists & inhibitors*
  • Recombinant Proteins / therapeutic use*
  • Sepsis / drug therapy*
  • Sialoglycoproteins / therapeutic use*
  • United States
  • United States Food and Drug Administration

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Antirheumatic Agents
  • IL1RN protein, human
  • Interleukin 1 Receptor Antagonist Protein
  • Protein C
  • Receptors, Interleukin-1
  • Recombinant Proteins
  • Sialoglycoproteins
  • drotrecogin alfa activated